Aphria insiders bought shares in Nuverra for next to nothing and then with Aphria purchase of Nuuvera at overvaluation approx. $5 per share for a company with $30,000 in 2017 revenues, they made out with approx. 100 million. If true this is very bad and maybe illegal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.